Skip navigation

News and Presentations for todays Controlled Drugs Summit

Overseeing the safer management of controlled drugs
Robert Allan,
Controlled Drugs Officer, Care Quality Commission
Pre-event Abstract
CQC are the regulator of health and care services across England and inspect and rate services.
Arrangements for controlled drugs within a service are assessed along with arrangements for all other medicines as part of CQC’s inspection processes. When we inspect services, we expect the arrangements in place for controlled drugs to cover all aspects of the controlled drug journey i.e. ordering and receipt, safe storage, record keeping, prescribing, clinical use, destruction and so on. The arrangements must include how to investigate and report concerns and should include auditing and monitoring. The arrangements should take account of current national guidance, such as the NICE guidance, NHS Improvement safety alerts and so on and be regularly reviewed to reflect developments. Our inspection findings feed into and inform our overall assessment of a service and whether we need to take any enforcement action.
To support organisations’ controlled drug arrangements, controlled drug self-assessment tools for both primary and secondary care organisations are published on our website. Providers can use them to generate their own action plan.
CQC also has responsibilities to help maintain a safe environment for CDs through its oversight of the implementation of The Controlled Drugs (Supervision and Management of Use) Regulations 2013. This follows on from the strengthened governance arrangements put in place for controlled drugs following the Shipman enquiry. CQC’s national controlled drug responsibilities include maintaining and publishing a register of all CD accountable officers across England, attending NHS England led controlled drug local intelligence networks, chairing a national group and associated sub-groups of regulators and agencies with a controlled drug remit and working collaboratively with cross border colleagues. Newsletters produced by the sub-groups to the Controlled Drugs National Group are published on the CD pages of the CQC website.
CQC’s controlled drug’s team report on their findings in an annual report to government and the report is published on the CQC website. Our latest eleventh annual report, covering January to December 2017, made four recommendations to strengthen existing arrangements for the reporting and sharing of controlled drug concerns across England. The report also includes an overview of prescribing data and identified prescribing trends. 
Full PowerPoint presentation

Developing the role of the Controlled Drugs Accountable Officer
William Rial, 
Controlled Drugs Accountable Officer, London Region, NHS England
Full PowerPoint Presentation

Also of Interest

A Practical Guide to Effective Non Medical Prescribing In Cardiology
Thursday 18 October 2018, Birmingham


Effective Non-Medical Prescribing in End of Life Care
Wednesday 5 December 2018, Manchester


Monitoring & Reducing Medication Errors & Harm in Hospitals National Summit 2018
Thursday 6 December 2018, Manchester

1 October 2018


    Partner Organisations

    The Tavistock and Portman NHS Foundation TrustInPracticeClinical Audit Support CentrePlayoutJust For Nurses
    GGI (Good Governance Institute) accredited conferences CPD Member BADS (British Association of Day Surgery) accredited conferences